CANF

Can-Fite BioPharma

11 hedge funds and large institutions have $3.2M invested in Can-Fite BioPharma in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Holders
11
Holders Change
+4
Holders Change %
+57.14%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TAM
1
Taylor Asset Management
Ontario, Canada
$2.01M 486,500 +138,000 +40%
Jane Street
2
Jane Street
New York
$592K 142,930 +142,930 New
Morgan Stanley
3
Morgan Stanley
New York
$347K 83,760 +83,760 New
VKH
4
Virtu KCG Holdings
New York
$61K 14,758 -7,284 -33%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$58K 13,953 +13,953 New
MC
6
Menta Capital
California
$51K 12,200
BG
7
Bollard Group
Massachusetts
$32K 7,686 +7,686 New
Bank of Montreal
8
Bank of Montreal
Ontario, Canada
$25K 6,000 +6,000 New
Citigroup
9
Citigroup
New York
$16K 3,954 +3,937 +23,159%
MFS
10
MSI Financial Services
Massachusetts
$4K 1,000 -1,000 -50%
UBS Group
11
UBS Group
Switzerland
-5,194 Closed
TRCT
12
Tower Research Capital (TRC)
New York
$0 69 -389 -85%